State-of-the-art: prostate LDR brachytherapy

dc.contributor.authorVoulgaris, S.en
dc.contributor.authorNobes, J. P.en
dc.contributor.authorLaing, R. W.en
dc.contributor.authorLangley, S. E.en
dc.date.accessioned2015-11-24T18:50:41Z
dc.date.available2015-11-24T18:50:41Z
dc.identifier.issn1476-5608-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18129
dc.rightsDefault Licence-
dc.subjectBrachytherapy/*methodsen
dc.subjectDose Fractionationen
dc.subjectFollow-Up Studiesen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectModels, Biologicalen
dc.subjectPatient Selectionen
dc.subjectProstatectomy/methodsen
dc.subjectProstatic Neoplasms/*radiotherapyen
dc.subjectQuality of Lifeen
dc.subjectRadiotherapy Dosageen
dc.titleState-of-the-art: prostate LDR brachytherapyen
heal.abstractThis article on low dose rate (LDR) prostate brachytherapy reviews long-term results, patient selection and quality of life issues. Mature results from the United States and United Kingdom are reported and issues regarding definitions of biochemical failure are discussed. Latest data comparing brachytherapy with radical prostatectomy or no definitive treatment and also the risk of secondary malignancies after prostate brachytherapy are presented. Urological parameters of patient selection and quality of life issues concerning urinary, sexual and bowel function are reviewed. The position of prostate brachytherapy next to surgery as a first-line treatment modality is demonstrated.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1038/pcan.2008.9-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/18364676-
heal.journalNameProstate Cancer Prostatic Disen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2008-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: